Western blot analyses from infigratinib‐resistant tumour collected at different passages indicated an elevation in cell cycle proteins such as cyclin E2, cyclin B1, Cdc25C, p‐Cdc2, cyclin D1, Rb and p‐Rb (Figure 3B). This evidence concerns the gene CCND1 and neoplasm.